Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01776606 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety Study of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
A Phase 3 study of Skin Aging, sponsored by Revance Therapeutics.
- Completed
- Registry status
- Phase 3
- Development phase
- 247
- Enrollment target
- 1
- Study location
NCT01776606 is a Phase 3 study of Skin Aging that has completed, run by Revance Therapeutics. The registered enrollment target is 247 participants, above the 48-participant average among 9 other Skin Aging trials with a reported enrollment target (415% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01776606, a Phase 3 study of Skin Aging, has completed, sponsored by Revance Therapeutics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 247 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the efficacy and safety of botulinum toxin type A compared to placebo control for the treatment of moderate to severe crow's feet lines.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Botulinum Toxin Type A
Study Locations (1)
Florida
- Dermatology Research Institute - Coral Gables
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 247 participants |
| Start Date | 2012-12 |
| Est. Completion | 2013-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01776606
The ClinicalTrials.gov registry entry for NCT01776606 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 247 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 48-participant average among 9 other Skin Aging trials with a reported enrollment target (415% higher). The listed sponsor is Revance Therapeutics, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Skin Aging appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01776606 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT01776606 about?
NCT01776606 is a clinical study titled "Efficacy and Safety Study of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines". This study will evaluate the efficacy and safety of botulinum toxin type A compared to placebo control for the treatment of moderate to severe crow's feet lines.
What is the current status of trial NCT01776606?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 247 participants. The study started on 2012-12. Estimated completion is 2013-05.
What conditions does trial NCT01776606 study?
This clinical trial studies the following conditions: Skin Aging.
What interventions are being tested in trial NCT01776606?
The interventions under investigation include: Placebo (DRUG), Botulinum Toxin Type A (DRUG).
Who is sponsoring clinical trial NCT01776606?
This trial is sponsored by Revance Therapeutics, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01776606 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging
ACTIVE NOT RECRUITING · NA
-
A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging, by Comparing to a Placebo
ACTIVE NOT RECRUITING · NA
-
Effect of Topical Sulforaphane on Skin Aging and With Ultraviolet and Visible Light Exposure
ACTIVE NOT RECRUITING · Early Phase 1
-
Clinical Trial to Evaluate the Efficacy of Skin Products to Improve Skin Quality and Health
COMPLETED · NA
-
Thermage CPT for Treatment of Facial and Neck Laxity
COMPLETED · NA
-
Relationship of Skin Related SNP to Topical Skin Care Product
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.